← Leaderboards
Stephen Lev Hoffman
Sanaria, Inc.
$79,440,588
Attributed
$84,538,777
Total exposure
36
Grants
31
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$84,538,777 · 36
By mechanism
R44$52,448,800 · 8
SB1$11,865,596 · 4
R43$11,743,428 · 20
U01$5,496,699 · 2
U44$2,984,254 · 2
Top collaborators
- Sumana Chakravarty9 shared
- Patrick E Duffy3 shared
- Eric R James2 shared
Others in their field
Top investigators on “Malaria”
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$82,291,297
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$61,561,099
- Karen L. Kotloff · University Of Maryland Baltimore$44,673,792
Research focus
MalariaVaccinesPlasmodium FalciparumSporozoitesClinical TrialsMalaria VaccinesAttenuatedParasitesSporozoite VaccineCulicidaeProtective EfficacyRadiationAfricaDoseChildSuccessBaseProductionSafetyInfectionMarketingCostCessation Of LifePrevent
Grant awards (116)
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites$1,000,000
U44 · FY2025 · AI
Progressing PfSPZ vaccines for malaria to licensure and commercialization$995,072
SB1 · FY2025 · AI · contact PI
Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines$945,493
U01 · FY2025 · AI · contact PI
Progressing PfSPZ vaccines for malaria to licensure and commercialization$999,345
SB1 · FY2024 · AI · contact PI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites$995,482
U44 · FY2024 · AI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine$968,360
R44 · FY2024 · AI · contact PI
Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines$942,943
U01 · FY2024 · AI · contact PI
Modularizing manufacture of PfSPZ vaccines: ookinete production for PfSPZ manufacture in mosquitoes and in vitro$277,702
R43 · FY2024 · AI · contact PI
Progressing PfSPZ vaccines for malaria to licensure and commercialization$999,921
SB1 · FY2023 · AI · contact PI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine$968,151
R44 · FY2023 · AI · contact PI
Automating mosquito microdissection for a malaria PfSPZ vaccine$957,878
R44 · FY2023 · AI · contact PI
Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines$942,943
U01 · FY2023 · AI · contact PI
Modularizing manufacture of PfSPZ vaccines: ookinete production for PfSPZ manufacture in mosquitoes and in vitro$282,240
R43 · FY2023 · AI · contact PI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine$999,306
R44 · FY2022 · AI · contact PI
PfSPZ Vaccine for Prevention of Plasmodium falciparum malaria$988,772
U44 · FY2022 · AI · contact PI
PfSPZ Vaccine for Malaria: Towards a Successful Biologics License Application and Commercialization$974,007
SB1 · FY2022 · AI · contact PI
Automating mosquito microdissection for a malaria PfSPZ vaccine$966,428
R44 · FY2022 · AI · contact PI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites$961,340
R44 · FY2022 · AI
In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine$947,054
R44 · FY2022 · AI · contact PI
Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines$942,943
U01 · FY2022 · AI · contact PI
Attenuation of Liquid Formulation for PfSPZ Vaccine by X-Ray$300,000
R43 · FY2022 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine$1,000,000
R44 · FY2021 · AI · contact PI
PfSPZ Vaccine for Malaria: Towards a Successful Biologics License Application and Commercialization$999,570
SB1 · FY2021 · AI · contact PI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites$977,419
R44 · FY2021 · AI · contact PI
In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine$965,661
R44 · FY2021 · AI · contact PI
Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines$942,943
U01 · FY2021 · AI · contact PI
Attenuation of Liquid Formulation for PfSPZ Vaccine by X-Ray$300,000
R43 · FY2021 · AI
A genetically modified Plasmodium falciparum sporozoite vaccine attenuated at the late-liver stage.$300,000
R43 · FY2021 · AI · contact PI
Enhancement of gametocytogenesis in Plasmodium falciparum by genetic engineering for improved PfSPZ Vaccine Manufacture$299,994
R43 · FY2021 · AI · contact PI
In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine$1,000,000
R44 · FY2020 · AI · contact PI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites$999,025
R44 · FY2020 · AI · contact PI
PfSPZ Vaccine for Malaria: Towards a Successful Biologics License Application and Commercialization$998,833
SB1 · FY2020 · AI · contact PI
Enhancement of gametocytogenesis in Plasmodium falciparum by genetic engineering for improved PfSPZ Vaccine Manufacture$300,000
R43 · FY2020 · AI · contact PI
A genetically modified Plasmodium falciparum sporozoite vaccine attenuated at the late-liver stage.$300,000
R43 · FY2020 · AI · contact PI
Marketing Strategic Plan and Distribution Logistics for Sanaria PfSPZ Vaccine against Malaria.$977,597
SB1 · FY2019 · AI · contact PI
Automating mosquito microdissection for a malaria PfSPZ vaccine$975,729
R44 · FY2019 · AI · contact PI
Development, GMP manufacture, and quality control release of a triple knock out genetically attenuated Plasmodium falciparum sporozoite vaccine$299,999
R43 · FY2019 · AI · contact PI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with a live attenuated sporozoite malaria vaccine$1,000,000
R44 · FY2018 · AI · contact PI
Marketing Strategic Plan and Distribution Logistics for Sanaria PfSPZ Vaccine against Malaria.$989,914
SB1 · FY2018 · AI · contact PI
Automating mosquito microdissection for a malaria PfSPZ vaccine$987,636
R44 · FY2018 · AI · contact PI
PfSPZ Vaccines: Quality Systems, Manufacturing, Regulatory, and Clinical Quality and Data Management Support for Product Commercialization$965,038
SB1 · FY2018 · AI · contact PI
Universal Attenuated Sporozoite Vaccine and Challenge System$951,398
R44 · FY2018 · AI · contact PI
Development, GMP manufacture, and quality control release of a triple knock out genetically attenuated Plasmodium falciparum sporozoite vaccine$299,999
R43 · FY2018 · AI · contact PI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with a live attenuated sporozoite malaria vaccine$1,000,000
R44 · FY2017 · AI · contact PI
In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine$999,997
R44 · FY2017 · AI · contact PI
Genetically Attenuated PfSPZ Malaria Vaccine$999,997
R44 · FY2017 · AI · contact PI
Automating mosquito microdissection for a malaria PfSPZ vaccine$997,637
R44 · FY2017 · AI · contact PI
Marketing Strategic Plan and Distribution Logistics for Sanaria PfSPZ Vaccine against Malaria.$996,292
SB1 · FY2017 · AI · contact PI
PfSPZ Vaccines: Quality Systems, Manufacturing, Regulatory, and Clinical Quality and Data Management Support for Product Commercialization$978,475
SB1 · FY2017 · AI · contact PI
Universal Attenuated Sporozoite Vaccine and Challenge System$970,426
R44 · FY2017 · AI · contact PI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites (PvSPZ Challenge) for controlled human malaria infection (CHMI)$300,000
R43 · FY2017 · AI · contact PI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with a live attenuated sporozoite malaria vaccine$1,000,000
R44 · FY2016 · AI · contact PI
In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine$999,997
R44 · FY2016 · AI · contact PI
Genetically Attenuated PfSPZ Malaria Vaccine$999,996
R44 · FY2016 · AI · contact PI
PfSPZ Vaccines: Quality Systems, Manufacturing, Regulatory, and Clinical Quality and Data Management Support for Product Commercialization$991,532
SB1 · FY2016 · AI · contact PI
Universal Attenuated Sporozoite Vaccine and Challenge System$989,298
R44 · FY2016 · AI · contact PI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites (PvSPZ Challenge) for controlled human malaria infection (CHMI)$300,000
R43 · FY2016 · AI · contact PI
In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine$999,996
R44 · FY2015 · AI · contact PI
Plasmodium Falciparum Whole Sporozoite Malaria Vaccine$999,995
R44 · FY2015 · AI · contact PI
Genetically Attenuated PfSPZ Malaria Vaccine$999,994
R44 · FY2015 · AI · contact PI
Automating mosquito microdissection for a malaria PfSPZ vaccine$299,999
R43 · FY2015 · AI · contact PI
PfSPZ Challenge with Chemoprophylaxis: Phase 1 Trial to Assess Liver Stage Drug$62,806
U01 · FY2015 · AI · contact PI
IMPROVING MANUFACTURING AND POTENCY OF CRYOPRESERVED MALARIA SPOROZOITE VACCINE$1,000,000
R44 · FY2014 · AI · contact PI
Universal Attenuated Sporozoite Vaccine and Challenge System$1,000,000
R44 · FY2014 · AI · contact PI
Plasmodium Falciparum Whole Sporozoite Malaria Vaccine$999,994
R44 · FY2014 · AI · contact PI
Automating mosquito microdissection for a malaria PfSPZ vaccine$299,999
R43 · FY2014 · AI · contact PI
Attenuated malaria sporozoite vaccine using a P. falciparum blood-stage auxotroph$299,998
R43 · FY2014 · AI · contact PI
Chloroquine Sensitive Plasmodium falciparum for MultiValent Vaccine & Challenge$297,678
R43 · FY2014 · AI · contact PI
PfSPZ Challenge with Chemoprophylaxis: Phase 1 Trial to Assess Liver Stage Drug$98,499
U01 · FY2014 · AI · contact PI
Universal Attenuated Sporozoite Vaccine and Challenge System$1,000,000
R44 · FY2013 · AI · contact PI
IMPROVING MANUFACTURING AND POTENCY OF CRYOPRESERVED MALARIA SPOROZOITE VACCINE$1,000,000
R44 · FY2013 · AI · contact PI
Plasmodium Falciparum Whole Sporozoite Malaria Vaccine$999,995
R44 · FY2013 · AI · contact PI
PfSPZ Challenge with Chemoprophylaxis: Phase 1 Trial to Assess Liver Stage Drug$618,129
U01 · FY2013 · AI · contact PI
Attenuated malaria sporozoite vaccine using a P. falciparum blood-stage auxotroph$299,998
R43 · FY2013 · AI · contact PI
High Throughput Assay to Identify New Drugs Against Vivax Malaria Liver Stages$299,998
R43 · FY2013 · AI · contact PI
Chloroquine Sensitive Plasmodium falciparum for MultiValent Vaccine & Challenge$299,996
R43 · FY2013 · AI · contact PI
Vaccination with purified, cryopreserved, infectious Plasmodium vivax sporozoites$299,934
R43 · FY2013 · AI · contact PI
Universal Attenuated Sporozoite Vaccine and Challenge System$1,000,000
R44 · FY2012 · AI · contact PI
IMPROVING MANUFACTURING AND POTENCY OF CRYOPRESERVED MALARIA SPOROZOITE VACCINE$1,000,000
R44 · FY2012 · AI · contact PI
Genetically Attenuated Malaria Attenuated Whole Parasite Sporozoite Vaccine$956,277
R44 · FY2012 · AI · contact PI
Vaccination with purified, cryopreserved, infectious Plasmodium vivax sporozoites$300,000
R43 · FY2012 · AI · contact PI
High Throughput Assay to Identify New Drugs Against Vivax Malaria Liver Stages$300,000
R43 · FY2012 · AI · contact PI
Increasing potency of attenuated sporozoite vaccines with a glycolipid adjuvant$292,654
R43 · FY2012 · AI · contact PI
Genetically Attenuated Malaria Attenuated Whole Parasite Sporozoite Vaccine$995,117
R44 · FY2011 · AI · contact PI
Attenuated Sporozoite Malaria Vaccine$983,532
R44 · FY2011 · AI · contact PI
Increasing potency of attenuated sporozoite vaccines with a glycolipid adjuvant$299,996
R43 · FY2011 · AI · contact PI
Automated Salivary Gland Dissection for Manufacture of Malaria PfSPZ Vaccine$299,627
R43 · FY2011 · AI · contact PI
Lyophilization of P. falciparum Transgenic for Trehalose Synthesis/Transport$284,756
R43 · FY2011 · AI · contact PI
In-vitro culture of Plasmodium falciparum sporozoites for malaria vaccine$269,927
R43 · FY2011 · AI · contact PI
Genetically Attenuated Malaria Attenuated Whole Parasite Sporozoite Vaccine$999,987
R44 · FY2010 · AI · contact PI
Attenuated Sporozoite Malaria Vaccine$993,465
R44 · FY2010 · AI · contact PI
Cryopreservation and delivery of sporozoite vaccine$993,429
R44 · FY2010 · AI · contact PI
Attenuated Sporozoite Malaria Vaccine$992,988
R44 · FY2010 · AI · contact PI
Universal Attenuated Malaria Sporozoite Vaccine and Challenge System$986,281
R44 · FY2010 · AI · contact PI
In-vitro culture of Plasmodium falciparum sporozoites for malaria vaccine$299,993
R43 · FY2010 · AI · contact PI
Automated Salivary Gland Dissection for Manufacture of Malaria PfSPZ Vaccine$299,989
R43 · FY2010 · AI · contact PI
Lyophilization of P. falciparum Transgenic for Trehalose Synthesis/Transport$299,983
R43 · FY2010 · AI · contact PI
Cryopreservation and delivery of sporozoite vaccine$999,910
R44 · FY2009 · AI · contact PI
Attenuated Sporozoite Malaria Vaccine$993,547
R44 · FY2009 · AI · contact PI
Cryopreservation and delivery of sporozoite vaccine$999,968
R44 · FY2008 · AI · contact PI
Universal Attenuated Malaria Sporozoite Vaccine and Challenge System$990,720
R44 · FY2008 · AI · contact PI
Genetically Attenuated Malaria Sporozote Vaccine$298,335
R43 · FY2008 · AI · contact PI
Attenuated Malaria Sporozoite Vaccine$999,981
R44 · FY2007 · AI · contact PI
Universal Attenuated Malaria Sporozoite Vaccine and Challenge System$990,311
R44 · FY2007 · AI · contact PI
Genetically Attenuated Malaria Sporozote Vaccine$300,000
R43 · FY2007 · AI · contact PI
Lyophilization of Plasmodium falciparum sporozoite vaccine$290,559
R43 · FY2007 · AI · contact PI
Attenuated Malaria Sporozoite Vaccine$999,955
R44 · FY2006 · AI · contact PI
Universal Attenuated Malaria Sporozoite Vaccine and Challenge System$990,645
R44 · FY2006 · AI · contact PI
Lyophilization of Plasmodium falciparum sporozoite vaccine$209,905
R43 · FY2006 · AI · contact PI
Attenuated Malaria Sporozoite Vaccine$999,980
R44 · FY2005 · AI
Aseptic, purified attenuated sporozite malaria vaccine$300,000
R43 · FY2005 · AI
Potency of cryopreserved, irradiated sporozoite vaccine$296,369
R43 · FY2005 · AI
Potency of cryopreserved, irradiated sporozoite vaccine$300,000
R43 · FY2004 · AI
Aseptic, purified attenuated sporozoite malaria vaccine$300,000
R43 · FY2004 · AI
Attenuated Malaria Sporozoite Vaccine$243,885
R43 · FY2004 · AI
Attenuated Malaria Sporozoite Vaccine$299,916
R43 · FY2003 · AI